Finn O. Larsen

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Neoadjuvant Chemotherapy vs Upfront Surgery in Patients With Locally Advanced Colon Cancer: A Randomized Clinical Trial.

Neoadjuvant Chemotherapy vs Upfront Surgery in Patients With Locally Advanced Colon Cancer: A Randomized Clinical Trial.

Journal: JAMA surgery

Published: March 04, 2026

Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study.

Nivolumab with or without Ipilimumab Combined with Stereotactic Body Radiotherapy in Patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 24, 2024

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials.

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials.

Journal: Frontiers in oncology

Published: June 07, 2022

Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer.

Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer.

Journal: Journal of hepatology

Published: September 29, 2021

Effects of a 12-Week Multimodal Exercise Intervention Among Older Patients with Advanced Cancer: Results from a Randomized Controlled Trial.

Effects of a 12-Week Multimodal Exercise Intervention Among Older Patients with Advanced Cancer: Results from a Randomized Controlled Trial.

Journal: The oncologist

Published: February 12, 2021

The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer.

The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer.

Journal: British journal of cancer

Published: January 22, 2021

Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status.

Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status.

Journal: International journal of cancer

Published: September 13, 2020

Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial.

Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial.

Journal: Cancers

Published: June 25, 2020

Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?

Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?

Journal: Clinical and translational radiation oncology

Published: October 06, 2019

Antitumour immunity invoked by hepatic arterial infusion of first-line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation: 8-12 years of follow-up.

Antitumour immunity invoked by hepatic arterial infusion of first-line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation: 8-12 years of follow-up.

Journal: International journal of cancer

Published: October 04, 2019

Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naïve Patients with Liver Metastases from Colorectal Cancer.

Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naïve Patients with Liver Metastases from Colorectal Cancer.

Journal: Oncology

Published: December 18, 2018

Systematic review: Incidence, risk factors, survival and treatment of bone metastases from colorectal cancer.

Systematic review: Incidence, risk factors, survival and treatment of bone metastases from colorectal cancer.

Journal: Journal of bone oncology

Published: September 10, 2018

Showing 1-12 of 29

Last Updated: 09/26/2026